Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor–targeted therapy with cetuximab and gefitinib
Rodney B. Luwor, Yang Lu, Xinqun Li, Ke Liang, Zhen FanVolume:
306
Year:
2011
Language:
english
Pages:
92
DOI:
10.1016/j.canlet.2011.02.035
File:
PDF, 502 KB
english, 2011